New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) - Forecast till 2030

New-Born Screening Market Overview

The new-born screening market is projected to reach USD 876.61 Million by 2030 at 8.20% CAGR during the forecast period 2022-2030

The new-born screening is a process of inspecting newborn babies using devices to find out the chances of having diseases that were invisible at the birth time. The increasing cases of new-born diseases have propelled the market growth in recent times. Government support for new-born screening processes has pushed the new-born screening market growth to the optimum level. The rising population of neo-natal and various types of new-born screening programs has ensured the escalation of new-born screening industry potential during the forecast years.

The incorporation of technological advancements in screening procedures has surged the growth of the new-born screening market size.  There is a rapid increase in the expenditure spent on the healthcare sector, and industry is an important factor that drives the new-born screening industry growth to maximum limits. Numerous benefits of the newborn screening test market impact the market growth positively. Governments of several regions are supporting and contributing towards the expansion of the new-born screening industry size. These governments are taking steps to raise awareness and different initiatives that will contribute towards the growth of the global market.

Several non-government and government organizations are facilitating care options for both baby and the mother. The American Society of Hematology launched a campaign in June 2018 to combat sickle cell disease in Africa and requested governments of that region for investing in the processes of new-born screening. The government is also encouraging manufacturers to develop other variety of screening tests by loosening their regulations in product manufacturing and marketing.

The US Food and Drug Administration or FDA in 2017 allowed the seeker system marketing for scanning four uncommon lysosomal storage disorders (LSDs) prevalent in newborn babies. The systems are designed specifically for detecting diseases like Gaucher, Fabry, Pompe, and Mucopolysaccharidosis Type I or MPS I. These initiatives by several governments and non-government organizations will thrust the potential new-born screening market industry in the near future.

The report provides a detailed analysis of the newborn screening market and the impact of the COVID19 pandemic on the new-born screening market growth. It covers the market dynamics and reflects the insights of market growth opportunities as well as threats. It includes the details of revenue estimation in the forecast period and the key players of the market that will influence the new-born screening industry share in the upcoming times. The report represents different segments of the market and geographical areas that can impact the potential of the new-born screening industry.

COVID19 Analysis

The impact of the coronavirus outbreak has shattered the global economy and pulled it downwards. A major crisis happened in the health sector as well as the financial sector. The closure of working areas and businesses has ruined the market stability worldwide. The economic growth rate has declined to lower levels, and financial struggle is seen everywhere globally. The lockdown restrictions completely shut down the industrial operations, which impacted the production of screening systems. However, the new-born screening market was still sustaining steady market growth. The reason behind the growth is the rapidly increasing cases of diseases in newborn babies.

During the pandemic, a significant rise in diseases demanded a heavy amount of screening systems which propelled the new-born screening market towards growth. The new-born screening industry is constantly working on producing new and advanced screening systems that will ensure better quality detection. The rising demand for newborn screening systems will expand the market size in the upcoming years.

Market Dynamics

• Major drivers of the market

The global new-born screening market is reaching optimum heights and is rapidly progressing in increasing the new-born screening industry size. The population of newborn babies is increasing day by day, which requires immense growth of the new-born screening industry. Technological advancements in developing the new-born screening systems will boost the new-born screening industry growth. Governments of several countries are supporting different newborn screening programs and taking numerous initiatives along with raising awareness among people about new-born screening and the advantages attached to it.

Various non-government and government organizations are providing better care options for the health of both baby and mother. The government is also relaxing regulations on the manufacturing and marketing of screening systems that will encourage manufacturers to produce better varieties of newborn screening systems. Campaigns for spreading awareness about diseases will evolve the potential of the new-born screening industry.

• Significant Opportunities for the market

The new-born screening market size will exhilarate quickly in the forecast years, and the rising demand for newborn screening systems will boost the market growth. Several technological advancements in the newborn screening system will behave as a market booster for the new-born screening industry growth. The increasing population of the new-born child will contribute immensely towards the expansion of the new-born screening industry share. Different countries' governments are also spreading awareness about the screening processes of newborn children and taking initiatives to support the new-born screening industry. All these opportunities will force the new-born screening market growth to a greater extent in the forecast period.

• Market Restraints

The coronavirus outbreak has impacted the new-born screening test market and became a major constraint in the market growth. The lockdown measures forced the manufacturing units and operations of industries to shut down. The demand to supply gap was getting broader, and the supply chain of industries was disrupted. But the pandemic had very less impact on the newborn screening test market. The increase in the newborn population demanded the rise of the new-born screening industry. The market potential will soon gain its momentum and excel in the near future.

• Market growth Challenges

The new-born screening market size is definitely expanding at a faster rate, but the market possesses certain challenges too. The scarcity of proper healthcare facilities and infrastructure is a bigger challenge in the path of new-born screening market growth. Newborn screening tests sometimes lack accuracy, which creates unreliability on the product. There are very few proficient professionals available who can handle the screening test properly, which creates a hindrance in the growth path of the new-born screening industry.

Value Chain Analysis

The value obtained by the newborn screening test market will rise to greater limits in the upcoming years. The new-born screening market share will exhilarate rapidly in the global economy. By the end of 2025, the new-born screening industry will reach optimum heights and contribute heavily to the worldwide economy.

Segment Overview

The global new-born screeningmarket is fragmented into different segments on the basis of technology, product, test type, and end-user. The newborn screening test market segmentation on the basis of technology includes DNA assays, tandem mass spectrometry, pulse oximetry, electrophoresis, hearing screening technology, immunoassays, and enzymatic assays. Pulse oximetry will grow rapidly in the newborn screening test market, and tandem mass spectrometry is predicted to grow during the forecast period. The market segmentation on the basis of the product involves reagents, instruments, and assay kits. The segment of the instrument is presumed to contribute more to the market in the forecast period as awareness about screening tests is increasing.

The new-born screening market segmentation on the basis of type tests comprises of different tests like critical congenital heart disease or CCHD test, dry blood spot test, hearing screening test, and urine test. The dry blood spot test is expected to hold a new-born screening market share in the upcoming years as the diseases in newborn babies are increasing. The market segmentation on the basis of end-user includes different sectors such as diagnostics centers, maternity and specialty clinics, hospitals, and many more. Hospitals will evolve more during the forecast period as government support helps the market grow.

Regional Analysis

The global new-born screening market is studied in different geographies such as North America, South America, Asia Pacific, Europe, Middle East, and Africa. The Americas have the majority control on the new-born screening market share as congenital disorder is prevalent in newborn babies. The rising population of newborn and government support boosts the market growth in this region boost the new-born screening market growth immensely. Following newborn screening programs is compulsory everywhere in North America and in the US, both federal and state governments make policies for supporting the new-born screening market.

Competitive Landscape of the market

The major players of new-born screening market are:

• Waters (US)


• SCIEX (US)


• Natus Medical Incorporated (US)


• PerkinElmer Inc. (US)


• Masimo Corporation (US)


• Bio-Rad Laboratories, Inc. (US)


• Agilent Technologies Inc. (US)


• GENERAL ELECTRIC (Boston)


• Medtronic PLC (Ireland)


• Trivitron Healthcare (India)


• Thermo Fisher Scientific Inc. (US)


• ZenTech SA (Belgium)